CirrhosisRx CDS System

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT05967273
Status
Recruiting
Apply to this trial

Conditions

  • Cirrhosis
  • Decision Support Systems, Clinical

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CirrhosisRx CDS — OTHER
    CirrhosisRx is a cirrhosis-specific CDS that organizes clinical data into clinically relevant groupings and links them to order sets consistent with national practice guidelines for inpatient cirrhosis care.

Study Details

The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.

Key Dates

Start date
Jan 14, 2025
Status verified
Mar 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
2,106 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: CirrhosisRx
    Providers in this arm will have access to the CirrhosisRx CDS system, which aggregates and organizes clinical data, presents them in clinically relevant/intuitive fashion for cirrhosis care, and linked to order sets consistent with national guidelines.
  • No Intervention: Usual Care
    Providers in this arm will not have access to the CirrhosisRx CDS system.

Primary Outcome Measure

Aggregate adherence to quality measures [ Time Frame: During the hospitalization, approximately 7 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San Francisco Medical CenterSan FranciscoCalifornia94143
Jin Ge, MD, MBA
[email protected]
415-502-8070

Find similar trials in San Francisco, CA

By research site
University of California San Francisco Medical Center· San Francisco, CA

Related Studies